Volume 18 Supplement 1

11th European Headache Federation Congress jointly with 31st National Congress of the Italian Society for the Study of Headaches

Meeting abstracts

Publication costs for this supplement were funded by the 11th European Headache Federation Congress and the 31st National Congress of the Italian Society for the Study of Headaches. PM is on the advisory boards for Allergan, Amgen, Teva, Novartis, ElectroCore, and speaker bureau for Allergan, Bayer, Sanofi. PM has received reimbursement from European Medicines Agency, Springer Nature and funding from Elytra Pharma. PM is an employee of Springer Nature. DDM has received honoraria from lecturing, research or clinical trial grants and consulting fees from Allergan, Amgen, Biogen, Brain Therapeutics, Eli Lily, Gammacore, Genesis Pharma, Novartis, Sanofi-Genzyme and Teva. FP declares no competing interest.

Rome, Italy01-03 December 2017